High IL-6/IFN-γ ratio could be associated with severe disease in COVID-19 patients.
作者信息
Lagunas-Rangel Francisco Alejandro, Chávez-Valencia Venice
机构信息
Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV), Mexico, Mexico.
Department of Nephrology, Hospital General Regional Hospital No. 1, Instituto Mexicano del Seguro Social, Morelia, Michoacán, Mexico.
出版信息
J Med Virol. 2020 Oct;92(10):1789-1790. doi: 10.1002/jmv.25900. Epub 2020 Jun 2.
Abstract
摘要
相似文献
1
High IL-6/IFN-γ ratio could be associated with severe disease in COVID-19 patients.高白细胞介素-6/干扰素-γ比值可能与新冠病毒肺炎患者的重症疾病有关。
J Med Virol. 2020 Oct;92(10):1789-1790. doi: 10.1002/jmv.25900. Epub 2020 Jun 2.
2
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.用于测量 COVID-19 患者体内 SARS-CoV-2 特异性反应的全血检测。
Clin Microbiol Infect. 2021 Feb;27(2):286.e7-286.e13. doi: 10.1016/j.cmi.2020.09.051. Epub 2020 Oct 10.
3
Complex immune deregulation in severe COVID-19: More than a mechanism of pathogenesis.重症 COVID-19 中的复杂免疫失调：不止是发病机制。
EBioMedicine. 2021 Nov;73:103673. doi: 10.1016/j.ebiom.2021.103673. Epub 2021 Nov 3.
4
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients.与 BNT162b2 mRNA 疫苗接种者对 SARS-CoV-2 产生有效免疫反应相关的系统性 IL-15、IFN-γ 和 IP-10/CXCL10 特征。
Cell Rep. 2021 Aug 10;36(6):109504. doi: 10.1016/j.celrep.2021.109504. Epub 2021 Jul 23.
5
IFN-γ cell response and IFN-γ release concordance after in vitro SARS-CoV-2 stimulation.体外 SARS-CoV-2 刺激后 IFN-γ 细胞反应和 IFN-γ 释放的一致性。
Eur J Clin Invest. 2021 Dec;51(12):e13636. doi: 10.1111/eci.13636. Epub 2021 Jun 24.
6
SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition.SARS-CoV-2 特异性 T 细胞应答与 COVID-19 患者易感性的相关性。
J Clin Invest. 2020 Dec 1;130(12):6477-6489. doi: 10.1172/JCI140965.
7
IL-6 Induction and Signaling: Horizons of COVID-19-Related Pathogenesis.白细胞介素-6的诱导与信号传导：新冠病毒相关发病机制的研究前沿
DNA Cell Biol. 2021 May;40(5):639-642. doi: 10.1089/dna.2021.0152. Epub 2021 Apr 13.
8
Increased Expression of Tim-3 Is Associated With Depletion of NKT Cells In SARS-CoV-2 Infection.Tim-3 表达增加与 SARS-CoV-2 感染中 NKT 细胞耗竭有关。
Front Immunol. 2022 Feb 16;13:796682. doi: 10.3389/fimmu.2022.796682. eCollection 2022.
9
Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.SARS-CoV-2 在 COVID-19 患者中的长期存在：宿主免疫、病毒毒力和传染性。
Virol Sin. 2020 Dec;35(6):793-802. doi: 10.1007/s12250-020-00308-0. Epub 2020 Nov 6.
10
Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.2019冠状病毒病危重症患者中与脓毒症相关的严重白细胞介素-6风暴
Cell Mol Immunol. 2020 Oct;17(10):1092-1094. doi: 10.1038/s41423-020-00522-6. Epub 2020 Sep 11.
引用本文的文献
1
Toxicities Associated with Systemic Administration of Interleukin-6 in Wistar Albino Rats.Wistar白化大鼠全身给予白细胞介素-6相关的毒性
J Exp Pharmacol. 2025 Aug 8;17:545-554. doi: 10.2147/JEP.S529995. eCollection 2025.
2
Biomarkers and early-onset acute kidney injury in critically ill COVID-19 patients, a prospective monocentric observational study.重症 COVID-19 患者的生物标志物与早发性急性肾损伤：一项前瞻性单中心观察性研究
BMC Nephrol. 2025 Jul 1;26(1):294. doi: 10.1186/s12882-025-04267-0.
3
Prospective Variation of Cytokine Trends during COVID-19: A Progressive Approach from Disease Onset until Outcome.COVID-19 期间细胞因子趋势的前瞻性变化：从发病到结局的递进方法。
Int J Mol Sci. 2024 Oct 1;25(19):10578. doi: 10.3390/ijms251910578.
4
SARS-CoV2 pneumonia patients admitted to the ICU: Analysis according to clinical and biological parameters and the extent of lung parenchymal lesions on chest CT scan, a monocentric observational study.SARS-CoV2 肺炎患者入住 ICU：根据临床和生物学参数以及胸部 CT 扫描肺实质病变程度进行的分析，一项单中心观察性研究。
PLoS One. 2024 Sep 19;19(9):e0308014. doi: 10.1371/journal.pone.0308014. eCollection 2024.
5
Immunomics in one health: understanding the human, animal, and environmental aspects of COVID-19.一体健康中的免疫组学：了解 COVID-19 的人类、动物和环境方面。
Front Immunol. 2024 Sep 4;15:1450380. doi: 10.3389/fimmu.2024.1450380. eCollection 2024.
6
Multiplex array analysis of circulating cytokines and chemokines in COVID-19 patients during the first wave of the SARS-CoV-2 pandemic in Milan, Italy.意大利米兰 SARS-CoV-2 大流行第一波期间 COVID-19 患者循环细胞因子和趋化因子的多重微阵列分析。
BMC Immunol. 2024 Jul 26;25(1):49. doi: 10.1186/s12865-024-00641-z.
7
Assessment of COVID-19 risk factors of early and long-term mortality with prediction models of clinical and laboratory variables.评估 COVID-19 风险因素与临床和实验室变量预测模型的早期和长期死亡率。
BMC Infect Dis. 2024 Jul 9;24(1):685. doi: 10.1186/s12879-024-09592-7.
8
Cytokine expression and mortality risk among COVID-19 hospitalized patients over 60 years of age in a referral hospital in Cartagena, Colombia.哥伦比亚卡塔赫纳一家转诊医院中60岁以上新冠肺炎住院患者的细胞因子表达与死亡风险
Heliyon. 2024 Apr 2;10(7):e29028. doi: 10.1016/j.heliyon.2024.e29028. eCollection 2024 Apr 15.
9
A Review on Role of Inflammation in Coronavirus Disease.炎症在冠状病毒病中的作用综述
Endocr Metab Immune Disord Drug Targets. 2024;24(13):1488-1505. doi: 10.2174/0118715303265274231204075802.
10
Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial.BCc1 和 Hep-S 纳米螯合药物联合治疗对住院中度 COVID-19 成年患者 IL-6 的有益作用：一项随机、双盲、安慰剂对照的临床试验。
Trials. 2023 Nov 11;24(1):720. doi: 10.1186/s13063-023-07624-2.
本文引用的文献
1
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19.基于中性粒细胞与淋巴细胞比值和IgG水平的免疫表型分析可预测COVID-19患者的疾病严重程度和预后。
Front Mol Biosci. 2020 Jul 3;7:157. doi: 10.3389/fmolb.2020.00157. eCollection 2020.
2
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.抗炎药物在治疗重症新型冠状病毒病 2019（COVID-19）患者中的应用：来自中国临床免疫学家的观点。
Clin Immunol. 2020 May;214:108393. doi: 10.1016/j.clim.2020.108393. Epub 2020 Mar 25.
3
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
4
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
7
Estimating the mean and variance from the median, range, and the size of a sample.根据中位数、极差和样本量估计均值和方差。
BMC Med Res Methodol. 2005 Apr 20;5:13. doi: 10.1186/1471-2288-5-13.
8
Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation.γ干扰素与白细胞介素-6信号之间的相互作用在急性炎症过程中调控中性粒细胞的迁移和凋亡。
J Clin Invest. 2003 Aug;112(4):598-607. doi: 10.1172/JCI17129.
Zotero 插件